Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting receptor tyrosine kinases involved in cancer cell proliferation. Shows potential in the development of targeted therapies for solid tumors due to its ability to cross cell membranes and bind selectively to ATP-binding sites in kinases. Also employed in structure-activity relationship (SAR) studies to optimize antitumor activity and reduce off-target effects in drug candidates.